118 related articles for article (PubMed ID: 26645061)
21. Trabectedin for recurrent WHO grade 2 or 3 meningiomas-Paving the road for new opportunities.
Alvarez-Breckenridge CA; Cahill DP; Brastianos PK
Neuro Oncol; 2022 May; 24(5):768-769. PubMed ID: 35100424
[No Abstract] [Full Text] [Related]
22. Medical Management of Meningiomas: Current Status, Failed Treatments, and Promising Horizons.
Karsy M; Guan J; Cohen A; Colman H; Jensen RL
Neurosurg Clin N Am; 2016 Apr; 27(2):249-60. PubMed ID: 27012389
[TBL] [Abstract][Full Text] [Related]
23. Mifepristone treatment in patients with surgically incurable sphenoid-ridge meningioma: a long-term follow-up.
de Keizer RJ; Smit JW
Eye (Lond); 2004 Sep; 18(9):954-8. PubMed ID: 15037887
[No Abstract] [Full Text] [Related]
24. Anaplastic meningioma: octreotide therapy for a case of recurrent and progressive intracranial disease.
Rammo R; Rock A; Transou A; Raghunathan A; Rock J
J Neurosurg; 2016 Feb; 124(2):496-500. PubMed ID: 26274993
[TBL] [Abstract][Full Text] [Related]
25. Tamoxifen/norfloxacin interaction leading to QT interval prolongation in a female patient with extracranial meningioma.
Slovacek L; Priester P; Petera J; Slanska I; Kopecky J
Bratisl Lek Listy; 2011; 112(6):353-4. PubMed ID: 21692412
[TBL] [Abstract][Full Text] [Related]
26. Treatment of unresectable skull base meningiomas with somatostatin analogs.
Schulz C; Mathieu R; Kunz U; Mauer UM
Neurosurg Focus; 2011 May; 30(5):E11. PubMed ID: 21529167
[TBL] [Abstract][Full Text] [Related]
27. Reapprasial of the role of endocrine therapy in meningioma management.
Chargari C; Védrine L; Bauduceau O; Le Moulec S; Ceccaldi B; Magné N
Endocr Relat Cancer; 2008 Dec; 15(4):931-41. PubMed ID: 18632875
[TBL] [Abstract][Full Text] [Related]
28. Light at the end of the tunnel: towards an effective drug therapy for surgery- and radiation-refractory meningioma.
Marosi C
Neuro Oncol; 2015 Jan; 17(1):7-8. PubMed ID: 25378633
[No Abstract] [Full Text] [Related]
29. Hydroxyurea for treatment of unresectable and recurrent meningiomas. I. Inhibition of primary human meningioma cells in culture and in meningioma transplants by induction of the apoptotic pathway.
Schrell UM; Rittig MG; Anders M; Kiesewetter F; Marschalek R; Koch UH; Fahlbusch R
J Neurosurg; 1997 May; 86(5):845-52. PubMed ID: 9126901
[TBL] [Abstract][Full Text] [Related]
30. Metastatic Atypical and Anaplastic Meningioma: A Case Series and Review of the Literature.
Kessler RA; Garzon-Muvdi T; Yang W; Weingart J; Olivi A; Huang J; Brem H; Lim M
World Neurosurg; 2017 May; 101():47-56. PubMed ID: 28143726
[TBL] [Abstract][Full Text] [Related]
31. The role of mifepristone in the management of meningiomas: A systematic review of literature.
Sharma R; Garg K; Katiyar V; Tandon V; Agarwal D; Singh M; Chandra SP; Suri A; Kale SS; Mahapatra AK
Neurol India; 2019; 67(3):698-705. PubMed ID: 31347538
[TBL] [Abstract][Full Text] [Related]
32. Everolimus effectively blocks pulmonary metastases from meningioma.
Bertolini F; Pecchi A; Stefani A; Fontana A; Rossi G
Neuro Oncol; 2015 Sep; 17(9):1301-2. PubMed ID: 26293327
[No Abstract] [Full Text] [Related]
33. Response of leptomeningeal metastases from breast cancer to hormonal therapy.
Chamberlain MC
Neurology; 2001 Feb; 56(3):425-6. PubMed ID: 11171923
[No Abstract] [Full Text] [Related]
34. Hydroxyurea for treatment of unresectable meningiomas.
Schrell UM; Rittig MG; Koch U; Marschalek R; Anders M
Lancet; 1996 Sep; 348(9031):888-9. PubMed ID: 8826822
[No Abstract] [Full Text] [Related]
35. Temozolomide combined with radiotherapy in the treatment of recurrent cranial meningioma previously treated with multiple surgical resections and two sessions of radiosurgery: a case report and literature review.
Scorsetti M; Alongi F; Clerici E; Navarria P; Simonelli M; Rognone E; Santoro A
Tumori; 2012; 98(3):67e-71e. PubMed ID: 22825521
[TBL] [Abstract][Full Text] [Related]
36. Medical treatment of recurrent meningiomas.
Chamberlain MC; Barnholtz-Sloan JS
Expert Rev Neurother; 2011 Oct; 11(10):1425-32. PubMed ID: 21955199
[TBL] [Abstract][Full Text] [Related]
37. Giving another chance to mifepristone in pharmacotherapy for aggressive meningiomas-A likely synergism with hydroxyurea?
Elmaci İ; Altinoz MA; Sav A; Yazici Z; Ozpinar A
Curr Probl Cancer; 2016; 40(5-6):229-243. PubMed ID: 27320011
[No Abstract] [Full Text] [Related]
38. Prolonged oral hydroxyurea and concurrent 3d-conformal radiation in patients with progressive or recurrent meningioma: results of a pilot study.
Hahn BM; Schrell UM; Sauer R; Fahlbusch R; Ganslandt O; Grabenbauer GG
J Neurooncol; 2005 Sep; 74(2):157-65. PubMed ID: 16193387
[TBL] [Abstract][Full Text] [Related]
39. Treatment of meningioma with octreotide.
Rünzi MW; Jaspers C; Windeck R; Benker G; Mehdorn M; Reinhardt V; Reinwein D
Lancet; 1989 Jul; 2(8656):217-8. PubMed ID: 2568544
[No Abstract] [Full Text] [Related]
40. Hydroxyurea for treatment of unresectable and recurrent meningiomas. II. Decrease in the size of meningiomas in patients treated with hydroxyurea.
Schrell UM; Rittig MG; Anders M; Koch UH; Marschalek R; Kiesewetter F; Fahlbusch R
J Neurosurg; 1997 May; 86(5):840-4. PubMed ID: 9126900
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
